Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06580457 · ClinicalTrials.gov registry record · NA

Personalized Approach to Healthy Use and Recovery (PATH) Trial

A NA study of Substance Use Disorder, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
74
Enrollment target
1
Study location

NCT06580457: Recruiting NA study of Substance Use Disorder, sponsored by VA Office of Research and Development.

NCT06580457 is a NA study of Substance Use Disorder that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 74 participants, below the 818-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06580457, a NA study of Substance Use Disorder, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

An important part of substance use treatment for many people is learning what triggers their substance use and urges, and how they can better manage those triggers. In this study, the investigators will generate a model for each individual that shows likely causal links between their substance use, urges, and comorbid symptoms (e.g., anxiety, depression, and PTSD), and the investigators will examine these models as a group to draw conclusions about common causes for substance use (and recovery) among Veterans with substance use disorders. The investigators will also test whether receiving a personal model and clinical feedback improves substance use disorder and comorbid symptom outcomes. Results will include both patient-reported and statistically-determined causes of substance use for individuals and groups, clinical impact of a personalized model and feedback session, and participant feedback about the relevance of this study and intervention.

Primary Outcome

Substance use will be measured as number of days each substance was used in the past 30 days using National Survey on Drug Use and Health questions. Substances measured are nicotine, alcohol, cannabis, cocaine/crack, heroin, hallucinogens, inhalants, methamphetamine, pain relievers, tranquilizers, sedatives, and prescription stimulants. For alcohol, we will also obtain number of drinks consumed on each day, and will analyze whether average number of drinks per drinking day has changed during eac

Conditions Studied

Interventions

  • BEHAVIORAL Personal Causal Model + Personalized Feedback

Study Locations (1)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2025-10-01
Est. Completion 2030-03-29
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06580457 shows while recruiting

NCT06580457 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 818-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Substance Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Personal Causal Model + Personalized Feedback is the first listed.

NCT06580457 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06580457 about?

NCT06580457 is a clinical study titled "Personalized Approach to Healthy Use and Recovery (PATH) Trial". An important part of substance use treatment for many people is learning what triggers their substance use and urges, and how they can better manage those triggers. In this study, the investigators will generate a model for each individual that shows likely causal links between their substance use, ...

What is the current status of trial NCT06580457?

This trial is currently recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2025-10-01. Estimated completion is 2030-03-29.

What conditions does trial NCT06580457 study?

This clinical trial studies the following conditions: Substance Use Disorder.

What interventions are being tested in trial NCT06580457?

The interventions under investigation include: Personal Causal Model + Personalized Feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT06580457?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06580457 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06580457's enrollment target sits among peer trials

74 13th of 18 higher than 6 of 18 other Substance Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06580457, the US trial registry maintained by the National Library of Medicine. NCT06580457 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.